These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 704164)

  • 1. [Development of repeated myocardial necrosis in animals with an ischemic infarct following exposure to an antigen from necrotic cardiac muscle].
    Fatenkov VN; Pechenina NV
    Patol Fiziol Eksp Ter; 1978; (4):6-9. PubMed ID: 704164
    [No Abstract]   [Full Text] [Related]  

  • 2. Localization of cardiac myosin-specific antibody in myocardial infarction.
    Khaw BA; Beller GA; Haber E; Smith TW
    J Clin Invest; 1976 Aug; 58(2):439-46. PubMed ID: 956377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Circulating cardiac antigens in animals with experimental myocardial infarct undergoing malaben pharmacotherapy].
    Gromova EG; Zubzhitskiĭ IuN; Parnova IL
    Farmakol Toksikol; 1983; 46(2):66-8. PubMed ID: 6602064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size.
    Reimer KA; Jennings RB
    Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of cytosolic and mitochondrial aspartate aminotransferase in normal, ischemic, and necrotic myocardium. An immunohistochemical study.
    Siegel RJ; Edwalds G; Rej R; Fishbein MC
    Lab Invest; 1984 Dec; 51(6):648-54. PubMed ID: 6389975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Precipitation reaction with antigen from necrotic heart muscle and the absolute amount of eosinophils in myocardialnfarct; diagnostic significance].
    Zakharova EA
    Ter Arkh; 1967 Sep; 39(9):77-8. PubMed ID: 5611708
    [No Abstract]   [Full Text] [Related]  

  • 7. [The clinico-immunological aspects of a repeat myocardial infarct].
    Trofimov GA
    Voen Med Zh; 1992 Sep; (9):32-4. PubMed ID: 1448943
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunopathology of myocardial infarct.
    Domaniewski J
    Pol Med J; 1970; 9(2):267-303. PubMed ID: 4912385
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modeling dystrophic myocardial lesions in dogs].
    Sagach VF
    Fiziol Zh; 1975; 21(2):201-6. PubMed ID: 1126477
    [No Abstract]   [Full Text] [Related]  

  • 10. [Use of the passive hemagglutination test for cardiac antigen detection in the blood of patients with ischemic heart disease].
    Mateshvili GG
    Lab Delo; 1972; 7():391-3. PubMed ID: 4124715
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiac antibodies in myocardial infarct (immunotermistographic studies].
    Nogaller AM; Levkoeva LG; Natanzon GE
    Ter Arkh; 1974; 46(11):108-12. PubMed ID: 4612830
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of immunological mechanisms in the pathogenesis of arteriosclerosis, stenocardia and myocardial infarct].
    Ananchenko VG; Gulevich NV; Griaznova NA; Iurazh VIa
    Sov Med; 1980; (4):77-81. PubMed ID: 7384885
    [No Abstract]   [Full Text] [Related]  

  • 13. Antigenic properties of the damaged heart muscle.
    Szabó S; Maros T; Lukács E; Ionescu M; Muntyán G
    Z Immunitatsforsch Allerg Klin Immunol; 1969 May; 137(5):492-500. PubMed ID: 4239402
    [No Abstract]   [Full Text] [Related]  

  • 14. Ischemic changes in the canine heart as affected by the dimethyl quaternary analog of propranolol, UM-272 (SC-27761).
    Lucchesi BR; Burmeister WE; Lomas TE; Abrams GD
    J Pharmacol Exp Ther; 1976 Nov; 199(2):310-28. PubMed ID: 978488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Detection of sensitized lymphocytes in myocardial infarct by the active rosette formation inhibition reaction].
    Reĭzenbuk VG; Lamp KM; Martin SI; Uuskiula MM
    Lab Delo; 1985; (1):38-40. PubMed ID: 2579272
    [No Abstract]   [Full Text] [Related]  

  • 16. [Informativeness of immunological reactions with myocardial antigen homogenates in myocardial infarct].
    Kitaev MI; Dvorkin MI
    Lab Delo; 1984; (3):153-7. PubMed ID: 6200677
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunomorphological aspects of myocardial infarct].
    Kiseleva AF; Pavlovich SI; Ishchenko VE; Petrova GV; Moĭseĭ VI
    Vrach Delo; 1987 Jul; (7):8-11. PubMed ID: 3307150
    [No Abstract]   [Full Text] [Related]  

  • 18. [Concentrations of glycosides in the myocardium and other tissues following experimental myocardial infarct in the dog].
    Kuhlmann J; Kötter V; von Leitner E; Arbeiter G; Schröder R; Rietbrock N
    Verh Dtsch Ges Kreislaufforsch; 1974; 40():296-300. PubMed ID: 4450672
    [No Abstract]   [Full Text] [Related]  

  • 19. [Implantation of skeletal muscle stem cells in inhibition of fibroatrophy of ischemic myocardium: an experimental study].
    Wei H; Zhu H; Zhao G
    Zhonghua Yi Xue Za Zhi; 2001 Nov; 81(22):1352-5. PubMed ID: 11930626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Importance of determining cardiac antibodies in myocardial infarct].
    Sochor K
    Voen Med Zh; 1981 Mar; (3):62. PubMed ID: 7222502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.